Profile: Novo Nordisk India Limited focuses on diabetes care. We treat haemostatic disorders. The treatment of haemophilia & related clotting disorders has been largely based on replacing the missing clotting factor with a substitute, typically obtained from human plasma or from recombinant (genetically engineered) preparations. Clotting factor substitutes are normally very effective. Since they are foreign proteins, some people develop inhibitors (antibodies) to them and, as a result, become resistant to further treatment. We provide insulin delivery devices. NovoPen® 3 is a durable pen that can be reused. It is one of the most widely used durable insulin pen.